December 31, 2024
3 min watch
CHICAGO — On this Healio Video Perspective from Eyecelerator@AAO, Sharon Bakalash, MD, PhD, CBA, of Astellas Ophthalmics, discusses the corporate’s pipeline for geographic atrophy in addition to AI’s rising function in treating the situation.
On the assembly, Astellas organized a panel of ophthalmic corporations to debate how AI could be utilized to profit geographic atrophy analysis.
“We’re doing this as a pharma firm as a result of we felt that there’s a must collate the entire neighborhood to seek out the options for this illness,” Bakalash stated.
She additionally highlighted Astellas’ plans for the worldwide launch of Izervay (avacincaptad pegol intravitreal resolution).
Sources/Disclosures
Collapse
Healio Interviews
Disclosures:
Bakalash reviews being world medical affairs head for Astellas Ophthalmics.
